Increasing Rates of Neoadjuvant Chemotherapy Are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2019.10.012